---
figid: PMC7551201__fonc-10-552283-g0002
figtitle: RAGE signaling pathway
organisms:
- NA
pmcid: PMC7551201
filename: fonc-10-552283-g0002.jpg
figlink: pmc/articles/PMC7551201/figure/F2/
number: F2
caption: RAGE signaling pathway. The receptor of advanced glycation end-products (RAGE)
  is associated to triggering proinflammatory intracellular signaling cascades once
  it is engaged by RAGE ligands, leading to consistent and robust cellular responses.
  Once engaged, multiple signaling pathways are triggering, including K-RAS, erk1/2
  MAP kinases, p38 and SAPK/JNK MAP kinases, Wnt/β-catenin pathway, NF-κB, AP-1, mTOR,
  Smad, PI3K, and the JAK/STAT pathways, with important downstream inflammatory and
  apoptotic marker secretions, which altogether leads to promotion of CRC. Butyrate,
  metformin, losartan, and sRAGE are RAGE–ligand interaction inhibitors.
papertitle: Receptor for Advanced Glycation End Products Acts as a Fuel to Colorectal
  Cancer Development.
reftext: Fatemeh Azizian-Farsani, et al. Front Oncol. 2020;10:552283.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8088099
figid_alias: PMC7551201__F2
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC7551201__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7551201__fonc-10-552283-g0002.html
  '@type': Dataset
  description: RAGE signaling pathway. The receptor of advanced glycation end-products
    (RAGE) is associated to triggering proinflammatory intracellular signaling cascades
    once it is engaged by RAGE ligands, leading to consistent and robust cellular
    responses. Once engaged, multiple signaling pathways are triggering, including
    K-RAS, erk1/2 MAP kinases, p38 and SAPK/JNK MAP kinases, Wnt/β-catenin pathway,
    NF-κB, AP-1, mTOR, Smad, PI3K, and the JAK/STAT pathways, with important downstream
    inflammatory and apoptotic marker secretions, which altogether leads to promotion
    of CRC. Butyrate, metformin, losartan, and sRAGE are RAGE–ligand interaction inhibitors.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AGER
  - MOK
  - TLR4
  - KRAS
  - SMAD2
  - SMAD3
  - MYD88
  - SMAD4
  - YAP1
  - MIR99A
  - CDC42
  - RAC1
  - RNASE1
  - MTOR
  - MAPK3
  - MAPK1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - CRK
  - MAPK14
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK8
  - MAPK9
  - MAPK10
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - CTNNB1
  - KLF5
  - S100A4
  - MYC
  - CRMP1
  - UTRN
  - DENR
  - DNM1L
  - DAPK2
  - FOS
  - FOSB
  - JUN
  - JUNB
  - JUND
  - NFKB1
  - SOX9
  - MDM2
  - MIR155
  - MIR21
  - IL1A
  - IL6
  - TNF
  - TP53
  - TP63
  - TP73
  - CCL7
  - SLC39A10
  - ZC3H12A
  - LCN2
  - ENPP2
  - CCL2
  - IL10
  - LTA
  - CXCL8
  - TGFB1
  - TGFB2
  - TGFB3
  - EGF
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - TIMP1
  - ARG1
  - TINAGL1
  - NOS2
  - ISYNA1
  - BCL2
  - RECK
  - SIRT1
  - ITGB1
  - MMP2
  - SP1
  - PSG1
  - DAND5
  - MMP9
  - Butyrate
  - Metformin
  - Losartan
  - Calcimycin
  - Arg
  - Vimnetin
  - glutamine
  - hypoxia
  - tumor
---
